Suppr超能文献

[糖基化脂蛋白作为糖尿病中的致动脉粥样硬化因子(文献综述)]

[Glycosylated lipoproteins as atherogenic factor in diabetes (review of the literature)].

作者信息

Denisenko T V

出版信息

Vopr Med Khim. 1990 Mar-Apr;36(2):5-10.

PMID:2194367
Abstract

Data on the role of glycosylated lipoproteins in atherogenesis are reviewed. Posttranslational modification of proteins involving nonenzymatic glycosylation occurred under conditions of normal state but the highest rate of these reactions was found in hyperglycemia (diabetes). Glycosylation, after blocking of the epsilon-amino group in lysyl residue in protein moiety of lipoproteins, transformed distinctly the physico-chemical and metabolic properties of apoproteins, as a result of which normal catabolism of lipoproteins was impaired. Reactions of glycosylation are mainly responsible for pathogenetic interrelationship between diabetes and atherosclerosis. Glycosylation of lipoproteins may contribute to development of atherosclerosis via autoimmunity mechanisms.

摘要

本文综述了糖基化脂蛋白在动脉粥样硬化发生过程中的作用。蛋白质的翻译后修饰涉及非酶糖基化,在正常状态下即可发生,但这些反应的最高速率出现在高血糖(糖尿病)状态。脂蛋白蛋白质部分赖氨酸残基的ε-氨基被封闭后发生糖基化,显著改变了载脂蛋白的物理化学和代谢特性,导致脂蛋白的正常分解代谢受损。糖基化反应是糖尿病与动脉粥样硬化之间发病机制相互关系的主要原因。脂蛋白糖基化可能通过自身免疫机制促进动脉粥样硬化的发展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验